A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...

GLP-1 drugs like semaglutide and tirzepatide have rewritten the rules of weight loss and diabetes care, but the story turns darker when the injections stop. People who come off these medications are ...

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss. Headlines often describe them as ...